Jump to Content
Jump to Main Navigation
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search
Table of Contents
Front Matter
Show Items
Automation and Information Technology–Positions
Show Items
Automation and Information Technology–Statements
Show Items
Automation and Information Technology–Guidelines
Show Items
Drug Distribution and Control–Positions
Show Items
Drug Distribution and Control–Guidelines
Show Items
Drug Distribution and Control: Procurement–Guidelines
Show Items
Drug Distribution and Control: Preparation and Handling–Positions
Show Items
Drug Distribution and Control: Preparation and Handling–Guidelines
Show Items
Drug Distribution and Control: Preparation and Handling–Technical Assistance Bulletin
Show Items
Drug Distribution and Control: Distribution–Positions
Show Items
Drug Distribution and Control: Distribution–Statements
Show Items
Drug Distribution and Control: Distribution–Technical Assistance Bulletins
Show Items
Education and Training–Positions
Show Items
Education and Training–Endorsed Document
Show Items
Ethics–Positions
Show Items
Ethics–Statements
Show Items
Ethics–Guideline
Show Items
Ethics–Endorsed Document
Show Items
Formulary Management (Medication-Use Policy Development)–Positions
Show Items
Formulary Management (Medication-Use Policy Development)–Statements
Show Items
Formulary Management (Medication-Use Policy Development)–Guidelines
Show Items
Formulary Management (Medication-Use Policy Development)–Endorsed Document
Show Items
Government, Law, and Regulation–Positions
Notification of Drug Product Price Increases (1904)
Mitigating Drug Product Shortages (1905)
Emergency Supplies of Drug Products (1906)
340B Drug Pricing Program Sustainability (1908)
Pharmacist Authority to Provide Medication-Assisted Treatment (1909)
Confidence in the U.S. Drug Approval and Regulatory Process (1803)
Impact of Drug Litigation Ads on Patient Care (1815)
Biosimilar Medications (1816)
Federal Quality Rating Program for Pharmaceutical Manufacturers (1818)
Intravenous Fluid Manufacturing Facilities as Critical Public Health Infrastructure (1819)
Partial Filling of Schedule II Prescriptions (1713)
Collaborative Practice (1715)
Greater Competition Among Generic and Biosimilar Manufacturers (1716)
Drug Product Supply Chain Integrity (1602)
Timely Board of Pharmacy Licensing (1621)
Inclusion of Drug Product Shortages in State Pricegouging Laws (1622)
Pharmacist Participation in Health Policy Development (1501)
Pharmacist Recognition as a Healthcare Provider (1502)
Premarketing Comparative Clinical Studies (1506)
Funding, Expertise, and Oversight of State Boards of Pharmacy (1507)
Support for FDA Expanded Access (Compassionate Use) Program (1508)
Development of Abuse-Resistant Narcotics (1512)
Quality Patient Medication Information (1513)
Automatic Stop Orders (1405)
Federal and State Regulation of Compounding (1406)
State Prescription Drug Monitoring Programs (1408)
Access to Oral Contraceptives Through an Intermediate Category of Drug Products (1410)
Expedited Pathways for FDA Drug Approval (1411)
FDA Oversight of Laboratory-Developed Tests (1412)
Regulation of Telepharmacy Services (1310)
Regulation of Centralized Order Fulfillment (1311)
DEA Scheduling of Controlled Substances (1315)
Pharmacy Technicians (1216)
Stable Funding for HRSA Office of Pharmacy Affairs (1219)
Globalization of Clinical Trials (1223)
Medical Marijuana (1101)
Agricultural Use of Hormone and Prohormone Therapies (1102)
Direct-to-Consumer Clinical Genetic Tests (1103)
Poison Control Center Funding (1121)
Health Insurance Coverage for U.S. Residents (1001)
Risk Evaluation and Mitigation Strategies (1002)
FDA Authority on Recalls (1003)
Postmarketing Comparative Clinical and Pharmacoeconomic Studies (1004)
Regulation of Home Medical Equipment Medication Products and Devices (1007)
Preservation of Antimicrobials for Medical Treatment (1009)
Use of Surrogate Endpoints for FDA Approval of Drug Uses (1011)
Regulation of Interstate Pharmacy Practice (0909)
Regulation of Dietary Supplements (0811)
Medicare Prescription Drug Benefit (0813)
FDA Authority to Prohibit Reuse of Brand Names (0719)
Minimum Effective Doses (0602)
Postmarketing Safety Studies (0515)
Mandatory Registry of Clinical Trials (0516)
Importation of Pharmaceuticals (0413)
FDA's Public Health Mission (0012)
Government, Law, and Regulation–Statements
Show Items
Medication Safety–Positions
Show Items
Medication Safety–Statements
Show Items
Medication Safety–Guidelines
Show Items
Medication Therapy and Patient Care: Organization and Delivery of Services–Positions
Show Items
Medication Therapy and Patient Care: Organization and Delivery of Services–Statements
Show Items
Medication Therapy and Patient Care: Organization and Delivery of Services–Guidelines
Show Items
Medication Therapy and Patient Care: Specific Practice Areas–Positions
Show Items
Medication Therapy and Patient Care: Specific Practice Areas–Statements
Show Items
Medication Therapy and Patient Care: Specific Practice Areas–Guidelines
Show Items
Pharmaceutical Industry: Drug Products, Labeling, and Packaging–Positions
Show Items
Pharmaceutical Industry: Industry: Marketing–Positions
Show Items
Pharmaceutical Industry: Industry: Marketing–Guideline
Show Items
Pharmacy Management–Positions
Show Items
Pharmacy Management–Statements
Show Items
Pharmacy Management–Guidelines
Show Items
Pharmacy Management: Compensation and Reimbursement–Positions
Show Items
Pharmacy Management: Human Resources–Positions
Show Items
Pharmacy Management: Human Resources–Guideline
Show Items
Pharmacy Management: Human Resources–Report
Show Items
Practice Settings–Positions
Show Items
Practice Settings–Guidelines
Show Items
Research–Positions
Show Items
Research–Statement
Show Items
Research–Guidelines
Show Items
ASHP Therapeutic Position Statements
Show Items
ASHP Therapeutic Guidelines
Show Items
Back Matter
Show Items
Poison Control Center Funding (1121)
in
Best Practices
Editor:
Bruce Hawkins
DOI:
https://doi.org/10.37573/9781585286560.147
Restricted access
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://publications.ashp.org/abstract/book/9781585286560/ch147.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
[35.170.82.159]
35.170.82.159
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size
